financetom
Business
financetom
/
Business
/
James River Group's Q3 adjusted net operating income rises to $17.4 mln
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
James River Group's Q3 adjusted net operating income rises to $17.4 mln
Nov 3, 2025 1:37 PM

Overview

* James River Q3 adjusted net operating income at $17.4 mln, showing improved performance

* Company's Q3 combined ratio improves to 94.0%, indicating better underwriting discipline

* James River plans redomicile from Bermuda to Delaware for operational efficiencies

Outlook

* Company expects to complete redomicile to Delaware by November 7, 2025

Result Drivers

* UNDERWRITING IMPROVEMENTS - Combined ratio improved to 94.0% from 135.5% due to better underwriting discipline

* E&S SEGMENT STRATEGY - E&S segment saw premium declines in some divisions but increases in smaller specialty divisions, focusing on profitability

* OPERATIONAL EFFICIENCIES - Planned redomicile from Bermuda to Delaware expected to add operational and expense efficiencies

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q3 Gross $237.30

Written mln

Premiums

Q3 $17.40

Adjusted mln

Operatin

g Income

Q3 94%

Combined

Ratio

Q3 28.30%

Expense

Ratio

Analyst Coverage

* The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 1 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the property & casualty insurance peer group is "buy"

* Wall Street's median 12-month price target for James River Group Holdings Ltd ( JRVR ) is $7.13, about 28.4% above its October 31 closing price of $5.10

* The stock recently traded at 4 times the next 12-month earnings vs. a P/E of 5 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Reynolds Consumer Products Likely to Deliver In-Line Q3 EPS, UBS Says
Reynolds Consumer Products Likely to Deliver In-Line Q3 EPS, UBS Says
Oct 23, 2024
03:34 PM EDT, 10/23/2024 (MT Newswires) -- Reynolds Consumer Products ( REYN ) is expected to report in-line Q3 earnings on Oct. 30, while revenue is likely to be below consensus, UBS said in a report Wednesday. The investment firm models earnings of $0.41 per share for the quarter, which is at the midpoint of the company's guidance of $0.39...
Good Times Restaurants Acquires Two Colorado Locations
Good Times Restaurants Acquires Two Colorado Locations
Oct 23, 2024
03:05 PM EDT, 10/23/2024 (MT Newswires) -- Good Times Restaurants ( GTIM ) said Wednesday it purchased two Good Times Burgers & Frozen Custard outlets in Broomfield and Northglenn, Colorado, from a franchisee. The restaurants reopened after two days of closure for digital menu board upgrades, new point-of-sale system installation, and team retraining, Good Times Restaurants ( GTIM ) said....
Tag Oil Prices Its Prior Announced $10-Million Share-Unit Offering
Tag Oil Prices Its Prior Announced $10-Million Share-Unit Offering
Oct 23, 2024
03:49 PM EDT, 10/23/2024 (MT Newswires) -- TAG Oil ( TAOIF ) on Wednesday priced its previously announced $10-million marketed public offering of units at $0.17 each. Each unit will include a share and a two-year warrant to buy a second share for $0.25. Some management members and directors plan to invest alongside other investors in this offering. Research Capital...
Update: Market Chatter: Catalent-Novo Holdings Deal Opposed by Roche CEO
Update: Market Chatter: Catalent-Novo Holdings Deal Opposed by Roche CEO
Oct 23, 2024
03:55 PM EDT, 10/23/2024 (MT Newswires) -- (Updates with Roche's response in the seventh paragraph.) Catalent's ( CTLT ) proposed takeover by Novo Holdings, the parent company of Novo Nordisk ( NVO ) , was opposed by Roche Chief Executive Thomas Schinecker, who urged the authorities to prevent the takeover as it may impact competition, Reuters reported Wednesday. Schinecker said...
Copyright 2023-2026 - www.financetom.com All Rights Reserved